10.1111/jnc.15521 [DOI] [PMC free article] [PubMed] [Google Scholar] Lin M., Cheng P., Hsiao P., Chen S., Hung C., Kuo C., et al
Thus, all adjuvant glucose-lowering therapies in type 1 diabetes are used off-label and contrary to local and national guidance [16]
Symptoms range from rash and itching to severe anaphylaxis, swelling or breathing issues
[1] The pivotal SURPASS trials, which evaluated tirzepatide in over 6,000 patients with type 2 diabetes, did not identify pharyngitis or throat pain as a significant treatment-related adverse event
The IGF-1/AKT/PKM2 axis not only controls energy metabolism but it can regulate gene expression and tissue homeostasis through STAT3 signaling
When the acetyl-CoA generated from the beta-oxidation of fats enters the Krebs cycle, it undergoes a series of transformations, eventually reaching the stage where succinate is converted into fumarate by the enzyme succinate dehydrogenase